TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02574494 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04076930 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04076930 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05688917 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05688917 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02287922 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT03182426 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05436730 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01514968 — Predictive Biomarker (PRD): SLCO1A2 mRNA
Genes: SLCO1A2; OATP; OATP1; OATP1A2; SLC21A3
Study NCT03248427 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03248427 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04036357 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT04226144 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04226144 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01347073 — Predictive Biomarker (PRD): HPN mRNA
Genes: HPN; TMPRSS1
Study NCT02827955 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT04459741 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00606632 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT02650206 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02083068 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT01068483 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01678508 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study NCT02411825 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT02411825 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02411825 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01599949 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT00676728 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT03515512 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT04505969 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02964247 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03817645 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT00555165 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00004883 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00910676 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03591510 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00296972 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02737774 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00858273 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02390947 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02390947 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02390947 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT00813605 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00436410 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02712723 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00054405 — Safety Biomarker (SAF): Interleukin 12
Study NCT00054405 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01555346 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03950154 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05093023 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT01808521 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01808521 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT03897283 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04470063 — Predictive Biomarker (PRD): DDO mRNA
Genes: DDO
Study NCT04293393 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04293393 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02439216 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01410214 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00013442 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT00428272 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT00428272 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01017835 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01495000 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01526057 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01526057 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00251329 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02666261 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03926351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03926351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03926351 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04069819 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04960904 — Predictive Biomarker (PRD): EVL mRNA
Genes: EVL; RNB6
Study NCT04395482 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06275438 — Predictive Biomarker (PRD): OXTR mRNA
Genes: OXTR
Study NCT00162825 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT01289678 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01597310 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00138008 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT02499731 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00005495 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04470648 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01174693 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01772043 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00919295 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00919295 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT01386801 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT05850117 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00819663 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02711410 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04376658 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01867918 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03505970 — Predictive Biomarker (PRD): MCTS1 mRNA
Genes: MCTS1; MCT1
Study NCT03505970 — Predictive Biomarker (PRD): SLC16A4 mRNA
Genes: SLC16A4; MCT4; MCT5
Study NCT02927535 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04653649 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02881502 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT02881502 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT02969044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02969044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04368338 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01027325 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01959633 — Predictive Biomarker (PRD): IFNAR1 mRNA
Genes: IFNAR1; IFNAR
Study NCT03348332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02118545 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT01514461 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02245087 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01841593 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02952469 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00002817 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00956423 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02721342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00029003 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02054052 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01057680 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02858791 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT00107029 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT03153358 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01805843 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03284723 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03284723 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00001271 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03051672 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03051672 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03051672 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02304393 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT02304393 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01690702 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03808480 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00681421 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00681421 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00681421 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00982657 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT02226523 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT02051348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01532401 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00122382 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03367819 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00591773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00064896 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01451463 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01094704 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT01132833 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT05606783 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03544723 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01276041 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02387840 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study NCT02387840 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02659384 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02286843 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03754010 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT03754010 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT03754010 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06267898 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01687894 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02908971 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00470535 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00308178 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00308178 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04044872 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00017693 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT03000231 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03520556 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03520556 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02034656 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02034656 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00041535 — Predictive Biomarker (PRD): OGT mRNA
Genes: OGT
Study NCT03911830 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02801123 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03579108 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00096629 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03524170 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03524170 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03524170 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02306993 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT02306993 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02689583 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02454933 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00494715 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00494715 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01077622 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02142608 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT04785547 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04451148 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00815464 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03348878 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03348878 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03765450 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02303912 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT02480517 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02534389 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00631046 — Predictive Biomarker (PRD): FADS1 mRNA
Genes: FADS1; FADSD5
Study NCT00631046 — Predictive Biomarker (PRD): FADS2 mRNA
Genes: FADS2
Study NCT02664181 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT06034964 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01900028 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02926066 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT02749617 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00795912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00795912 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04311294 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT02864576 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02864576 — Safety Biomarker (SAF): BDNF
Study NCT02139280 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02139280 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02846766 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT00684840 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04447131 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04340466 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02621866 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00521794 — Predictive Biomarker (PRD): KCNJ2 mRNA
Genes: KCNJ2; IRK1
Study NCT04074187 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT04074187 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04074187 — Surrogate Endpoint (SUR): Platelet count response
Study NCT02603588 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT02603588 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT00254592 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03918629 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01437293 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00485511 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT04720105 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT00324077 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00324077 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01019434 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT01551771 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CCR3 mRNA
Genes: CCR3; CMKBR3
Study NCT01339403 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02325128 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT00908635 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04276831 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04092309 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00277329 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00277329 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT02601014 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01149863 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00017095 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00573378 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01280643 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01280643 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT00395590 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00395590 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01680991 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01841684 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02060305 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00276484 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03503604 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03503604 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02205463 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03241641 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03241641 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03241641 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03782168 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03782168 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03923140 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT03923140 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02623725 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03992521 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03992521 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03992521 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03992521 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03992521 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT00627159 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04364893 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02711202 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5